We are live on
!
Find out more
CC
Callan Capital Portfolio holdings
AUM
$1.35B
Turnover
17.35%
1-Year Est. Return
8.35%
This Fund
S&P 500
This Quarter
Est. Return
+6.61%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$361M
AUM Growth
-$12.5M
(-3.3%)
Cap. Flow
-$18.7M
Cap. Flow
% of AUM
-5.16%
Top 10 Holdings %
Top 10 Hldgs %
73.48%
Holding
81
New
7
Increased
17
Reduced
22
Closed
16
Avg Time Held
0.8
years
Top 10 Avg Time Held
0.9
years
Top 20 Avg Time Held
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
+$1.82M |
| 2 |
Global X MLP & Energy Infrastructure ETF
MLPX
|
+$1.53M |
| 3 |
BIOMED REALTY TRUST INC
BMR
|
+$1.31M |
| 4 |
Vanguard FTSE Europe ETF
VGK
|
+$1.06M |
| 5 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$709K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alerian MLP ETF
AMLP
|
+$21.4M |
| 2 |
PIMCO Enhanced Low Duration Active Exchange-Traded Fund
LDUR
|
+$1.25M |
| 3 |
PIMCO Active Bond Exchange-Traded Fund
BOND
|
+$917K |
| 4 |
ZVO
Zovio Inc. Common Stock
ZVO
|
+$738K |
| 5 |
SZYM
SOLAZYME INC COM STK (DE)
SZYM
|
+$498K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 96.12% |
| 2 | Healthcare | 2.22% |
| 3 | Real Estate | 0.47% |
| 4 | Technology | 0.4% |
| 5 | Consumer Staples | 0.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
IPCM
51
DELISTED
IPC HEALTHCARE INC COM DTD
IPCM
| $371K | 0.1% |
8,293
| – | – |
2014 Q2
1 quarter
|
|
|
CUDA
52
DELISTED
Barracuda Networks, Inc.
CUDA
| $353K | 0.1% |
+13,750
| New | +$387K |
2014 Q3
0 quarters
|
|
|
IMUC
53
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
| $351K | 0.1% |
9,848
| – | – |
2013 Q2
5 quarters
|
|
|
SGYP
54
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $329K | 0.09% |
118,200
-14,000
| -11% | -$50.8K |
2013 Q4
3 quarters
|
|
55
Tesla
TSLA
$1.42T
| $326K | 0.09% |
20,175
+3,000
| +17% | +$49.5K |
2014 Q2
1 quarter
|
|
|
ARNA
56
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $319K | 0.09% |
7,612
+1,000
| +15% | +$44.6K |
2014 Q2
1 quarter
|
|
57
WisdomTree US LargeCap Dividend Fund
DLN
$6.33B
| $268K | 0.07% |
7,520
-834
| -10% | -$29.7K |
2013 Q2
5 quarters
|
|
58
Illumina
ILMN
$39.2B
| $261K | 0.07% |
1,637
| – | – |
2014 Q1
2 quarters
|
|
59
Acadia Pharmaceuticals
ACAD
$3.33B
| $248K | 0.07% |
+10,000
| New | +$234K |
2014 Q3
0 quarters
|
|
60
State Street SPDR S&P 500 ETF Trust
SPY
$811B
| $205K | 0.06% |
+1,041
| New | +$206K |
2014 Q3
0 quarters
|
|
61
iShares Core S&P 500 ETF
IVV
$885B
| $202K | 0.06% |
+1,020
| New | +$203K |
2014 Q3
0 quarters
|
|
62
DELISTED
Assertio
ASRT
| $152K | 0.04% |
167
| – | – |
2014 Q2
1 quarter
|
|
|
TLRA
63
DELISTED
Telaria, Inc.
TLRA
| $100K | 0.03% |
42,828
| – | – |
2014 Q1
2 quarters
|
|
64
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| – | – |
0
| – | – |
2014 Q2
1 quarter
|
|
|
65
Alerian MLP ETF
AMLP
$12.6B
| – | – |
-225,452
| Closed | -$21.4M | – |
|
|
66
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.61B
| – | – |
-8,412
| Closed | -$917K | – |
|
67
Coeur Mining
CDE
$16B
| – | – |
-17,000
| Closed | -$156K | – |
|
68
Hecla Mining
HL
$10.4B
| – | – |
-15,000
| Closed | -$52K | – |
|
69
Kinross Gold
KGC
$28.5B
| – | – |
-19,500
| Closed | -$81K | – |
|
|
70
PIMCO Enhanced Low Duration Active Exchange-Traded Fund
LDUR
$1.32B
| – | – |
-12,288
| Closed | -$1.25M | – |
|
71
Paramount Gold Nevada
PZG
$91.4M
| – | – |
-13,085
| Closed | -$13K | – |
|
72
Qualcomm
QCOM
$188B
| – | – |
-2,809
| Closed | -$222K | – |
|
73
Vanguard Real Estate ETF
VNQ
$37B
| – | – |
-3,721
| Closed | -$278K | – |
|
74
Vanguard Total World Stock ETF
VT
$81.7B
| – | – |
-3,478
| Closed | -$216K | – |
|
75
Solitario Resources
XPL
$48.4M
| – | – |
-22,000
| Closed | -$29K | – |
|
Similar funds
PRO
MBA
SIA
AP
MW
SBIA
LC
TW
Callan Capital's Q3 2014 Portfolio in Review
As of Q3 2014, Callan Capital held 81 positions worth $361M, down 3.3% from $374M the previous quarter. Its ten largest holdings account for 73% of the portfolio.
Callan Capital withdrew a net $18.7M in Q3 2014, closing 16 positions and reducing 22 holdings. Its most notable exit was Alerian MLP ETF, an estimated $21.4M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 96% of assets, down from 96% a quarter earlier, followed by Healthcare and Real Estate.
Against the trend, Callan Capital opened a new position in Global X MLP & Energy Infrastructure ETF worth $1.53M.
- Callan Capital's largest Q3 2014 buy was Global X MLP & Energy Infrastructure ETF: 25,667 shares worth $1.53M.
- Callan Capital added most to RECEPTOS INC COM STK (DE) in Q3 2014, an estimated $1.82M increase.
- Callan Capital's biggest Q3 2014 reduction was Zovio Inc. Common Stock, cutting an estimated $738K.
- Callan Capital fully exited Alerian MLP ETF in Q3 2014, selling an estimated $21.4M.
- Callan Capital's ten largest holdings make up 73% of its $361M portfolio in Q3 2014.
- Callan Capital opened 7 new positions and closed 16 in Q3 2014.
- Callan Capital's portfolio value fell 3.3% quarter-over-quarter to $361M.
Based on Callan Capital's 13F filing for Q3 2014, filed 12 Nov 2014.